VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1581594
Sex: M
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experiencing symptoms exactly like covid symptoms; slept the day away; never ate or drank; lips was looking dehydrated; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination. The patient's past medical history included COVID-19 in October 2020. Concomitant products included ATORVASTATIN, CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), FINASTERIDE, LISINOPRIL, TAMSULOSIN and VALACYCLOVIR [VALACICLOVIR] for an unknown indication. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jan-2021, the patient experienced SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired). At the time of the report, SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 100.2 (High) 100.2. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient did not take any treatment. The patient had COVID-19 in Oct-2020. It was 8 days prior to fulfilling the 3 month waiting period when he received the vaccine. He was very ill with the covid symptoms for about 12 hours the next day. This happened for just one day. The patient did not take anything for his symptoms.

Other Meds: ATORVASTATIN; CALTRATE [CALCIUM CARBONATE]; FINASTERIDE; LISINOPRIL; TAMSULOSIN; VALACYCLOVIR [VALACICLOVIR]

Current Illness:

ID: 1581595
Sex: F
Age: 68
State: LA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm swollen; Arm is hurting; Arm is warm to the touch; Arm is red down to the elbow; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swollen), PAIN IN EXTREMITY (Arm is hurting), FEELING HOT (Arm is warm to the touch) and ERYTHEMA (Arm is red down to the elbow) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm swollen), PAIN IN EXTREMITY (Arm is hurting), FEELING HOT (Arm is warm to the touch) and ERYTHEMA (Arm is red down to the elbow). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Arm swollen), PAIN IN EXTREMITY (Arm is hurting), FEELING HOT (Arm is warm to the touch) and ERYTHEMA (Arm is red down to the elbow) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1581596
Sex: M
Age:
State: NJ

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diarrhea/possible food poisoning; diarrhea/possible food poisoning; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea/possible food poisoning) and FOOD POISONING (diarrhea/possible food poisoning) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea/possible food poisoning) and FOOD POISONING (diarrhea/possible food poisoning). At the time of the report, DIARRHOEA (diarrhea/possible food poisoning) and FOOD POISONING (diarrhea/possible food poisoning) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1581597
Sex: F
Age:
State: TX

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Thinks she has start of a sinus infection; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Thinks she has start of a sinus infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The patient's past medical history included No adverse reaction. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced SINUSITIS (Thinks she has start of a sinus infection). The patient was treated with AMOXICILLIN at an unspecified dose and frequency. At the time of the report, SINUSITIS (Thinks she has start of a sinus infection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. concomitant medication was not provided.

Other Meds:

Current Illness:

ID: 1581598
Sex: F
Age: 65
State: UT

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; terrible aching; headache; nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 25-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (terrible aching), HEADACHE (headache) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), MYALGIA (terrible aching), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, PYREXIA (fever), MYALGIA (terrible aching), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. concomitant medication was not provided.

Other Meds:

Current Illness:

ID: 1581599
Sex: F
Age: 63
State: CA

Vax Date: 02/03/2021
Onset Date: 02/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; chills; vomiting; Rash is itchy; developed rash all over body, started on thighs and then lip was swelling; developed rash all over body, started on thighs and then lip was swelling; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 25-Feb-2021. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever), CHILLS (chills), VOMITING (vomiting), RASH (developed rash all over body, started on thighs and then lip was swelling) and LIP SWELLING (developed rash all over body, started on thighs and then lip was swelling) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No reported medical history). Concomitant products included VITAMINS NOS. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced RASH (developed rash all over body, started on thighs and then lip was swelling) and LIP SWELLING (developed rash all over body, started on thighs and then lip was swelling). On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills), VOMITING (vomiting) and RASH PRURITIC (Rash is itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and METHYLPREDNISOLONE (MEDROL DOSEPAK) at an unspecified dose and frequency. At the time of the report, PYREXIA (fever), CHILLS (chills), VOMITING (vomiting), RASH (developed rash all over body, started on thighs and then lip was swelling), LIP SWELLING (developed rash all over body, started on thighs and then lip was swelling) and RASH PRURITIC (Rash is itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1581600
Sex: U
Age:
State: IL

Vax Date: 02/08/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Positive SARS-CoV-2; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. No Medical History information was reported. On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test positive: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant and treatment medications were reported.

Other Meds:

Current Illness:

ID: 1581601
Sex: F
Age:
State: ME

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (arm soreness) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (arm soreness). At the time of the report, INJECTION SITE PAIN (arm soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information was not provided. Concomitant information was not provided.

Other Meds:

Current Illness:

ID: 1581602
Sex: F
Age:
State: GA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever 101.0 and 100.0; Very bad headache; A spontaneous report was received from a consumer concerning who received Modern's COVID-19 vaccine (mRNA-1273) patient who developed very bad headache and fever of 101 ,100.0. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. The patient received their second of two planned doses of mRNA-1273 (Batch number: 013M20A) ON 22-FEB-2021, same day prior to the onset of the events intramuscularly for prophylaxis of COVID-19 infection. Treatment information was not provided. Therefore, action taken with the drug in response to the event is not applicable. The outcome of the events were unknown.

Other Meds:

Current Illness: No adverse event

ID: 1581603
Sex: F
Age: 67
State: TX

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: patient's arm has been a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (patient's arm has been a little sore) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The patient's past medical history included Hodgkin's disease ((Hodgkins Lymphoma)). On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (patient's arm has been a little sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (patient's arm has been a little sore) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1581604
Sex: F
Age: 72
State: IL

Vax Date: 01/25/2021
Onset Date: 02/23/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: first shot that got inflamed and itchy; little swelling, redness, itching, and the usual pain; little swelling, redness, itching, and the usual pain; little swelling, redness, itching, and the usual pain; little swelling, redness, itching, and the usual pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (first shot that got inflamed and itchy), VACCINATION SITE PRURITUS (little swelling, redness, itching, and the usual pain), VACCINATION SITE SWELLING (little swelling, redness, itching, and the usual pain), VACCINATION SITE ERYTHEMA (little swelling, redness, itching, and the usual pain) and VACCINATION SITE PAIN (little swelling, redness, itching, and the usual pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 012M20A) for COVID-19 vaccination. The patient's past medical history included Iliotibial band syndrome (left side) in 2019, Bronchiectasis in 2019 and Rosacea in 2000. Concurrent medical conditions included Sulfonamide allergy (sulfa), Drug allergy (Demerol), Drug allergy (altaryl), Drug allergy (hydrocodone-acetaminophen), Drug allergy (Sudafed), Myofascitis (Worst flare-up ever) since 2010, Hip arthritis since 2019 and Osteopenia. Concomitant products included ALBUTEROL [SALBUTAMOL] for Cough, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Multiple allergies, BACLOFEN for Myofascitis, VITAMIN K [VITAMIN K NOS] and CALCIUM CARBONATE, COLECALCIFEROL (CAL-D) for Osteopenia. On 25-Jan-2021 at 2:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021 at 1:35 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021 at 2:30 PM, the patient experienced VACCINATION SITE INFLAMMATION (first shot that got inflamed and itchy). 23-Feb-2021 at 2:30 PM, the patient experienced VACCINATION SITE PRURITUS (little swelling, redness, itching, and the usual pain), VACCINATION SITE SWELLING (little swelling, redness, itching, and the usual pain), VACCINATION SITE ERYTHEMA (little swelling, redness, itching, and the usual pain) and VACCINATION SITE PAIN (little swelling, redness, itching, and the usual pain). The patient was treated with CORTISONE ongoing since an unknown date at an unspecified dose and frequency and CORTISONE for Adverse event, at an unspecified dose and frequency. On 27-Feb-2021, VACCINATION SITE INFLAMMATION (first shot that got inflamed and itchy), VACCINATION SITE PRURITUS (little swelling, redness, itching, and the usual pain), VACCINATION SITE SWELLING (little swelling, redness, itching, and the usual pain), VACCINATION SITE ERYTHEMA (little swelling, redness, itching, and the usual pain) and VACCINATION SITE PAIN (little swelling, redness, itching, and the usual pain) had resolved. The patient felt strange that the sight of second shot did not react at all. It was first shot site that had all the reactions. Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional information received reporter contact details, patient demographics, medical history, event and dosage details updated. On 03-Aug-2021: Significant follow-up received. Updated patient height, medical history and event outcome. Start date of concomitant medication for calcium-d and vitamin K was added.

Other Meds: BACLOFEN; VITAMIN K [VITAMIN K NOS]; ALBUTEROL [SALBUTAMOL]; FLONASE [FLUTICASONE PROPIONATE]; CAL-D

Current Illness: Drug allergy (Sudafed); Drug allergy (hydrocodone-acetaminophen); Drug allergy (Demerol); Drug allergy (altaryl); Hip arthritis; Myofascitis (Worst flare-up ever); Osteopenia; Sulfonamide allergy (sulfa)

ID: 1581605
Sex: F
Age:
State:

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced DIZZINESS (Dizziness) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported.

Other Meds:

Current Illness:

ID: 1581606
Sex: M
Age: 38
State: IL

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; chills; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever) and CHILLS (chills) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (Fever) and CHILLS (chills). At the time of the report, PYREXIA (Fever) and CHILLS (chills) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the events was not applicable. Concomitant and treatment information not provided.

Other Meds:

Current Illness:

ID: 1581607
Sex: F
Age: 66
State: MI

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; chills; vomiting; injection arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), CHILLS (chills), VOMITING (vomiting) and VACCINATION SITE PAIN (injection arm soreness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 vaccination. No medical history was provided by the reporter. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced HEADACHE (headache), CHILLS (chills), VOMITING (vomiting) and VACCINATION SITE PAIN (injection arm soreness). At the time of the report, HEADACHE (headache), CHILLS (chills), VOMITING (vomiting) and VACCINATION SITE PAIN (injection arm soreness) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: POTASSIUM 99; HYDROCODONE; MULTIVITAMINS [VITAMINS NOS]; VITAMIN D [VITAMIN D NOS]; LYRICA

Current Illness:

ID: 1581608
Sex: F
Age: 55
State: CA

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: weakness in legs; pain at injection; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (weakness in legs), VACCINATION SITE PAIN (pain at injection) and FATIGUE (fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced MUSCULAR WEAKNESS (weakness in legs), VACCINATION SITE PAIN (pain at injection) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK. On 29-Jan-2021, MUSCULAR WEAKNESS (weakness in legs), VACCINATION SITE PAIN (pain at injection) and FATIGUE (fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1581609
Sex: F
Age: 81
State: AL

Vax Date: 01/28/2021
Onset Date: 02/02/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy red bumps on her torso (front and back); bumps on her torso (front and back); red bumps on her torso (front and back); This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy red bumps on her torso (front and back)), PAPULE (bumps on her torso (front and back)) and ERYTHEMA (red bumps on her torso (front and back)) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PRURITUS (Itchy red bumps on her torso (front and back)), PAPULE (bumps on her torso (front and back)) and ERYTHEMA (red bumps on her torso (front and back)). At the time of the report, PRURITUS (Itchy red bumps on her torso (front and back)), PAPULE (bumps on her torso (front and back)) and ERYTHEMA (red bumps on her torso (front and back)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1581610
Sex: F
Age: 76
State: MI

Vax Date: 02/16/2021
Onset Date: 02/24/2020
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: firmness at the site of injection; itching at injection site; redness/pinkness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (firmness at the site of injection), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (redness/pinkness at the site of injection) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031420A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included METFORMIN, GLIPIZIDE, METOPROLOL, LISINOPRIL and WARFARIN for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2020, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE ERYTHEMA (redness/pinkness at the site of injection). On 24-Feb-2021, the patient experienced VACCINATION SITE INDURATION (firmness at the site of injection) and VACCINATION SITE PRURITUS (itching at injection site). At the time of the report, VACCINATION SITE INDURATION (firmness at the site of injection), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (redness/pinkness at the site of injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: METFORMIN; GLIPIZIDE; METOPROLOL; LISINOPRIL; WARFARIN

Current Illness:

ID: 1581611
Sex: F
Age:
State:

Vax Date: 01/26/2021
Onset Date: 02/03/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: stressed out and have hives; stressed out and have hives; This spontaneous case was reported by a consumer and describes the occurrence of STRESS (stressed out and have hives) and URTICARIA CHOLINERGIC (stressed out and have hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Hives. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced URTICARIA CHOLINERGIC (stressed out and have hives). On an unknown date, the patient experienced STRESS (stressed out and have hives). At the time of the report, STRESS (stressed out and have hives) and URTICARIA CHOLINERGIC (stressed out and have hives) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1581612
Sex: F
Age: 60
State: OR

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diarrhea lasted several days; fatigue; headaches; nausea lasted several days; terrible congestion, upper respiratory related; lost of appetite; lost of taste; This spontaneous case was reported by a consumer and describes the occurrence of UPPER RESPIRATORY TRACT CONGESTION (terrible congestion, upper respiratory related), DECREASED APPETITE (lost of appetite), AGEUSIA (lost of taste), DIARRHOEA (diarrhea lasted several days) and FATIGUE (fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2021, the patient experienced UPPER RESPIRATORY TRACT CONGESTION (terrible congestion, upper respiratory related), DECREASED APPETITE (lost of appetite), DIARRHOEA (diarrhea lasted several days), FATIGUE (fatigue), HEADACHE (headaches) and NAUSEA (nausea lasted several days). In January 2021, the patient experienced AGEUSIA (lost of taste). At the time of the report, UPPER RESPIRATORY TRACT CONGESTION (terrible congestion, upper respiratory related), DECREASED APPETITE (lost of appetite), AGEUSIA (lost of taste), DIARRHOEA (diarrhea lasted several days), FATIGUE (fatigue), HEADACHE (headaches) and NAUSEA (nausea lasted several days) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative (Negative) Negative twice. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1581613
Sex: F
Age: 66
State: OH

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cant keep down fluids, and diarrhea; Nausea; Vomiting; Abdominal Cramps; Felt terrible; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal Cramps), FEELING ABNORMAL (Felt terrible), DIARRHOEA (cant keep down fluids, and diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced ABDOMINAL PAIN (Abdominal Cramps), FEELING ABNORMAL (Felt terrible), NAUSEA (Nausea) and VOMITING (Vomiting). On 04-Feb-2021, the patient experienced DIARRHOEA (cant keep down fluids, and diarrhea). At the time of the report, ABDOMINAL PAIN (Abdominal Cramps), FEELING ABNORMAL (Felt terrible), DIARRHOEA (cant keep down fluids, and diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. The patient took no treatment.

Other Meds:

Current Illness:

ID: 1581614
Sex: M
Age:
State: MA

Vax Date: 01/17/2021
Onset Date: 02/14/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm pain; fatigue; Fever (100.4F); This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Arm pain), FATIGUE (fatigue) and PYREXIA (Fever (100.4F)) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced INJECTION SITE PAIN (Arm pain), FATIGUE (fatigue) and PYREXIA (Fever (100.4F)). On 16-Feb-2021, INJECTION SITE PAIN (Arm pain), FATIGUE (fatigue) and PYREXIA (Fever (100.4F)) had resolved. Not Provided No concomitant medications reported by investigator o No treatment medications provided by the reporter. This case was linked to MOD-2021-024269 (Patient Link).

Other Meds:

Current Illness:

ID: 1581615
Sex: M
Age: 76
State: PA

Vax Date: 01/14/2021
Onset Date: 02/09/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness; Body ache; Nausea; Chills; Sore arm; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body aches), DIZZINESS (dizziness), PAIN (Body ache) and NAUSEA (Nausea) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), HCTZ, LISINOPRIL, SERTRALINE, SIMVASTATIN, BIMATOPROST (LUMIGAN) and DORZOLAMIDE for an unknown indication. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and PAIN (Body aches). On 23-Feb-2021, the patient experienced DIZZINESS (dizziness), PAIN (Body ache), NAUSEA (Nausea) and CHILLS (Chills). On 10-Feb-2021, PAIN (Body aches) had resolved. On 11-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, DIZZINESS (dizziness), PAIN (Body ache), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown. The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable. Treatment information was not provided. This case was linked to MOD-2021-024355 (Patient Link).

Other Meds: BABY ASPIRIN; HCTZ; LISINOPRIL; SERTRALINE; SIMVASTATIN; LUMIGAN; DORZOLAMIDE

Current Illness:

ID: 1581616
Sex: F
Age:
State: NC

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: looks like an allergic reaction; still does not feel real good; her cheeks gets red; Stomach has a bunch of growling and gassy like; 3 to 4 hours of vomiting; very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (looks like an allergic reaction), FEELING ABNORMAL (still does not feel real good), RASH ERYTHEMATOUS (her cheeks gets red), FLATULENCE (Stomach has a bunch of growling and gassy like) and INJECTION SITE PAIN (very sore arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and METOPROLOL for an unknown indication. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced INJECTION SITE PAIN (very sore arm). On 29-Jan-2021, the patient experienced VACCINATION COMPLICATION (looks like an allergic reaction), FEELING ABNORMAL (still does not feel real good), RASH ERYTHEMATOUS (her cheeks gets red), FLATULENCE (Stomach has a bunch of growling and gassy like) and VOMITING (3 to 4 hours of vomiting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Feb-2021, VOMITING (3 to 4 hours of vomiting) had resolved. At the time of the report, VACCINATION COMPLICATION (looks like an allergic reaction), FEELING ABNORMAL (still does not feel real good), RASH ERYTHEMATOUS (her cheeks gets red), FLATULENCE (Stomach has a bunch of growling and gassy like) and INJECTION SITE PAIN (very sore arm) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Tylenol and Ibuprofen used as a Treatment medication

Other Meds: SYNTHROID; METOPROLOL

Current Illness:

ID: 1581617
Sex: F
Age: 30
State: MN

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore throat; Swollen tonsils; Multiple cycles each month; cold like symptoms; minor headach/Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), TONSILLAR HYPERTROPHY (Swollen tonsils), MENSTRUATION IRREGULAR (Multiple cycles each month), NASOPHARYNGITIS (cold like symptoms) and HEADACHE (minor headach/Headache) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Migraine in 2004. Concurrent medical conditions included Anxiety since 2012. Concomitant products included SERTRALINE for Anxiety. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced HEADACHE (minor headach/Headache) and FATIGUE (Fatigue). On 02-Feb-2021, the patient experienced NASOPHARYNGITIS (cold like symptoms). On 03-Feb-2021, the patient experienced MENSTRUATION IRREGULAR (Multiple cycles each month). On 23-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and TONSILLAR HYPERTROPHY (Swollen tonsils). On 30-Jan-2021, HEADACHE (minor headach/Headache) and FATIGUE (Fatigue) had resolved. On 27-Feb-2021, NASOPHARYNGITIS (cold like symptoms) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat) and TONSILLAR HYPERTROPHY (Swollen tonsils) outcome was unknown and MENSTRUATION IRREGULAR (Multiple cycles each month) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No treatment information was reported. The patient not had any actute illness at the time of vaccination and up to 1 month before.The patient had not experienced similar adverse event in the past and not had other potential causes for the event.Beginning in February 2021, The patient began to had her period twice a month. She had that each month to date (August 2021). In April, she had her intrauterine device (IUD) checked to make sure that had not become misplaced. The ultra sound showed that her IUD was still in place. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Additional information received: Suspect product information and reporter contact details updated. On 03-Aug-2021: Follow-up received: Patient details, relevant medical history added, Dosing regimen added, concomitant medication information added, new events added as a fatigue, Irregular menstrual cycle and cold and narrative updated.

Other Meds: SERTRALINE

Current Illness: Anxiety

ID: 1581618
Sex: F
Age: 83
State: FL

Vax Date: 02/02/2021
Onset Date: 02/05/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: large red area on the arm; area was bumpy like a rash; A spontaneous report was received from a Consumer concerning a 83-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events large red area on the arm(erythema), area was bumpy like a rash(rash). The patient's medical history was not provided. No relevant concomitant medications were reported. On 2 Feb 2021,approximately 4 days prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 038K20A) intramuscularly in arm for prophylaxis of COVID-19 infection. On 5 Feb 2021, the patient experienced the event(s) large red area on the arm and area was bumpy like a rash. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s) large red area on the arm and area was bumpy like a rash was considered resolved on 15 Feb 2021. .

Other Meds:

Current Illness:

ID: 1581619
Sex: M
Age: 81
State: CA

Vax Date: 01/28/2021
Onset Date: 02/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: PAIN AT THE INJECTION SITE; CHILLS; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (PAIN AT THE INJECTION SITE) and CHILLS (CHILLS) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. UNKNOWN and UNKNOWN) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced INJECTION SITE PAIN (PAIN AT THE INJECTION SITE) and CHILLS (CHILLS). At the time of the report, INJECTION SITE PAIN (PAIN AT THE INJECTION SITE) and CHILLS (CHILLS) had not resolved. Not Provided No concomitant medications reported by investigator TYLENOL AND ORANGE JUICE used as Treatment medication.

Other Meds:

Current Illness:

ID: 1581620
Sex: U
Age:
State: TX

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shoulder was sore; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder was sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (shoulder was sore). At the time of the report, ARTHRALGIA (shoulder was sore) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were reported.

Other Meds:

Current Illness:

ID: 1581621
Sex: F
Age: 24
State: MD

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body aches; chills; chest pains; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Feb-2021 and was forwarded to Moderna on 05-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), CHILLS (chills), CHEST PAIN (chest pains) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for an unknown indication. The patient's past medical history included No adverse event. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), CHILLS (chills), CHEST PAIN (chest pains) and HEADACHE (headache). At the time of the report, PAIN (body aches), CHILLS (chills), CHEST PAIN (chest pains) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Treatment includes Tylenol and Advil. Patient was taking Centamin previously but stopped a few month ago.

Other Meds:

Current Illness:

ID: 1581622
Sex: U
Age:
State: AL

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: enlarged lymph node (in armpit) on the opposite arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (enlarged lymph node (in armpit) on the opposite arm) in a 22-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (enlarged lymph node (in armpit) on the opposite arm). At the time of the report, LYMPHADENOPATHY (enlarged lymph node (in armpit) on the opposite arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications and treatment information were reported.

Other Meds:

Current Illness:

ID: 1581623
Sex: F
Age:
State:

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Temperature; Diarrhea; Pain in the chest; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), BODY TEMPERATURE INCREASED (Temperature), DIARRHOEA (Diarrhea), CHEST PAIN (Pain in the chest) and FATIGUE (Very tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced CHILLS (Chills), BODY TEMPERATURE INCREASED (Temperature), DIARRHOEA (Diarrhea), CHEST PAIN (Pain in the chest) and FATIGUE (Very tired). At the time of the report, CHILLS (Chills), BODY TEMPERATURE INCREASED (Temperature), DIARRHOEA (Diarrhea), CHEST PAIN (Pain in the chest) and FATIGUE (Very tired) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1581624
Sex: F
Age: 87
State: NY

Vax Date: 02/15/2021
Onset Date: 02/23/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy knot; Red knot; Warm to the touch at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy knot), ERYTHEMA (Red knot) and INJECTION SITE WARMTH (Warm to the touch at the site of injection) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PRURITUS (Itchy knot), ERYTHEMA (Red knot) and INJECTION SITE WARMTH (Warm to the touch at the site of injection). At the time of the report, PRURITUS (Itchy knot), ERYTHEMA (Red knot) and INJECTION SITE WARMTH (Warm to the touch at the site of injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information and concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1581625
Sex: F
Age: 67
State: MD

Vax Date: 02/22/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arthritis Pain; Neuropathic Pain; I still have enlarged underarm lymph nodes.; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis Pain), NEURALGIA (Neuropathic Pain) and LYMPHADENOPATHY (I still have enlarged underarm lymph nodes.) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Arthritis since 01-Dec-2020 and Neuropathic pain since 01-Dec-2020. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (Arthritis Pain), NEURALGIA (Neuropathic Pain) and LYMPHADENOPATHY (I still have enlarged underarm lymph nodes.). At the time of the report, ARTHRITIS (Arthritis Pain) and NEURALGIA (Neuropathic Pain) was resolving and LYMPHADENOPATHY (I still have enlarged underarm lymph nodes.) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided. No treatment medication was provided. Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow up received contains added event - Lymphadenopathy and updated outcome from not recovered to recovering

Other Meds:

Current Illness: Arthritis; Neuropathic pain

ID: 1581626
Sex: U
Age:
State: AL

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: doesn't feel well at all today; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (doesn't feel well at all today), HEADACHE (headache) and CHILLS (chills) in a 22-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (doesn't feel well at all today), HEADACHE (headache) and CHILLS (chills). At the time of the report, MALAISE (doesn't feel well at all today), HEADACHE (headache) and CHILLS (chills) outcome was unknown. No concomitant medications and treatment information were reported. This case was linked to MOD-2021-024388 (Patient Link).

Other Meds:

Current Illness:

ID: 1581627
Sex: F
Age: 76
State: FL

Vax Date: 01/22/2021
Onset Date: 01/30/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm was red size of my palm; hot arm; itchy arm; hard arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Feb-2021 and was forwarded to Moderna on 05-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm was red size of my palm), FEELING HOT (hot arm), PRURITUS (itchy arm) and INDURATION (hard arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included METFORMIN, PRAVASTATIN, POTASSIUM (POTASIUM M), ACETYLSALICYLIC ACID (BABY ASPIRIN), LOSARTAN, METOPROLOL and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 22-Jan-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced ERYTHEMA (arm was red size of my palm), FEELING HOT (hot arm), PRURITUS (itchy arm) and INDURATION (hard arm). On 03-Feb-2021, FEELING HOT (hot arm), PRURITUS (itchy arm) and INDURATION (hard arm) had resolved. At the time of the report, ERYTHEMA (arm was red size of my palm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included Benadryl when itching badly.

Other Meds: METFORMIN; PRAVASTATIN; POTASIUM M; BABY ASPIRIN; LOSARTAN; METOPROLOL; SYNTHROID

Current Illness:

ID: 1581628
Sex: F
Age: 70
State:

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Delayed Swelling bruise; Delayed itchy brusie; Delayed red bruise; Tiny bruise the size of a penny; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (Tiny bruise the size of a penny), VACCINATION SITE SWELLING (Delayed Swelling bruise), INJECTION SITE PRURITUS (Delayed itchy brusie) and INJECTION SITE ERYTHEMA (Delayed red bruise) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. Concurrent medical conditions included Sulfonamide allergy. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE BRUISING (Tiny bruise the size of a penny). On 19-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Delayed Swelling bruise), INJECTION SITE PRURITUS (Delayed itchy brusie) and INJECTION SITE ERYTHEMA (Delayed red bruise). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE BRUISING (Tiny bruise the size of a penny), VACCINATION SITE SWELLING (Delayed Swelling bruise), INJECTION SITE PRURITUS (Delayed itchy brusie) and INJECTION SITE ERYTHEMA (Delayed red bruise) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. treatment information includes ice. No concomitant medications were reported Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: ADR Form received on 11-MAY-2021 Contains patient details updated , medical history was updated.

Other Meds:

Current Illness: Sulfonamide allergy

ID: 1581629
Sex: F
Age: 65
State: WI

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: having sweats; lethargy; body aches; low grade fever; joint pain; headache; muscle pain; chills; A spontaneous report was received from a Consumer concerning a 65- years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sweats(hyperhidrosis), lethargy(lethargy), chills(chills), low grade fever(pyrexia), headache(headache), joint pain(arthralgia), muscle pain(myalgia ) and body aches(pain). The patient's medical history was not provided. No relevant concomitant medications were reported. On24 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (batch: 023M20A) in the left arm for prophylaxis of COVID-19 infection. On 24 Feb 2021, at 8 PM the patient experienced sweats, lethargy, chills, low grade fever, headache, joint pain, muscle pain and body aches. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, sweats, lethargy, chills, low grade fever, headache, joint pain, muscle pain and body aches were unknown.

Other Meds:

Current Illness:

ID: 1581630
Sex: F
Age: 85
State: CA

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: redness at the injection site 4.5 to 5 inches; blotchy at the injection site; arm sort of itchy; headache; swelling at the injection site after the shot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Feb-2021 and was forwarded to Moderna on 05-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site after the shot), VACCINATION SITE ERYTHEMA (redness at the injection site 4.5 to 5 inches), INJECTION SITE DISCOLOURATION (blotchy at the injection site), PRURITUS (arm sort of itchy) and HEADACHE (headache) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included blood pressure medicine for an unknown indication. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site after the shot) and HEADACHE (headache). On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site 4.5 to 5 inches), INJECTION SITE DISCOLOURATION (blotchy at the injection site) and PRURITUS (arm sort of itchy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Jan-2021, HEADACHE (headache) had resolved. At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site after the shot), VACCINATION SITE ERYTHEMA (redness at the injection site 4.5 to 5 inches), INJECTION SITE DISCOLOURATION (blotchy at the injection site) and PRURITUS (arm sort of itchy) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: blood pressure medicine

Current Illness:

ID: 1581631
Sex: M
Age:
State: TN

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Minor itching; Oval shaped rash; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness), VACCINATION SITE PRURITUS (Minor itching) and VACCINATION SITE RASH (Oval shaped rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (Soreness). On 24-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Minor itching) and VACCINATION SITE RASH (Oval shaped rash). On 12-Feb-2021, MYALGIA (Soreness) outcome was unknown. At the time of the report, VACCINATION SITE PRURITUS (Minor itching) and VACCINATION SITE RASH (Oval shaped rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications and treatment information were reported.

Other Meds:

Current Illness:

ID: 1581632
Sex: F
Age:
State: CA

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Violent shaking; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Violent shaking) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The patient's past medical history included No adverse reaction (no historical condition was reported). On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced TREMOR (Violent shaking) and CHILLS (Chills). At the time of the report, TREMOR (Violent shaking) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1581633
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lethargy; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no historical condition was reported). On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LETHARGY (lethargy). At the time of the report, LETHARGY (lethargy) outcome was unknown. No concomitants or treatment medications were reported.

Other Meds:

Current Illness:

ID: 1581634
Sex: F
Age:
State: IA

Vax Date: 02/08/2021
Onset Date: 02/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever of 103.1; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 103.1) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PYREXIA (fever of 103.1). At the time of the report, PYREXIA (fever of 103.1) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication and treatment information were not reported. The reporter not sure whether the patient and Patient's partner had food poisoning and that was caused the fever.

Other Meds:

Current Illness:

ID: 1581635
Sex: F
Age: 68
State: CA

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extremely tired and sluggish; More tired and sluggish than usual thereafter; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extremely tired and sluggish) and SLUGGISHNESS (More tired and sluggish than usual thereafter) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no historical condition was reported). On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Extremely tired and sluggish) and SLUGGISHNESS (More tired and sluggish than usual thereafter). At the time of the report, FATIGUE (Extremely tired and sluggish) and SLUGGISHNESS (More tired and sluggish than usual thereafter) outcome was unknown. No concomitants or treatment medications were reported.

Other Meds:

Current Illness:

ID: 1581636
Sex: F
Age: 74
State: SC

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of injection site rash (rash at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included: No historical conditions reported. On Feb 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced injection site rash (rash at the injection site). At the time of the report, injection site rash (rash at the injection site): not resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitants or treatment medications reported.

Other Meds:

Current Illness:

ID: 1581637
Sex: F
Age: 69
State: AR

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a pain they have from a ruptured disk, they had since before but sometimes it flairs up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (a pain they have from a ruptured disk, they had since before but sometimes it flairs up) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes, Blood pressure high and Cholesterol. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (a pain they have from a ruptured disk, they had since before but sometimes it flairs up). At the time of the report, PAIN (a pain they have from a ruptured disk, they had since before but sometimes it flairs up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patients medical history included ruptured disk. Concomitant product included high blood pressure medications, diabetes oral medication and cholesterol medication. Treatment information was not provided.

Other Meds:

Current Illness: Blood pressure high; Cholesterol; Diabetes

ID: 1581638
Sex: F
Age:
State:

Vax Date:
Onset Date: 02/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in her arm; Sinus disorder; Drainage from nose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in her arm), SINUSITIS (Sinus disorder) and RHINORRHOEA (Drainage from nose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm), SINUSITIS (Sinus disorder) and RHINORRHOEA (Drainage from nose). At the time of the report, PAIN IN EXTREMITY (Pain in her arm), SINUSITIS (Sinus disorder) and RHINORRHOEA (Drainage from nose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no concomitant medications reported. no treatment details reported.

Other Meds:

Current Illness:

ID: 1581639
Sex: F
Age: 68
State: MA

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nausea again; her eyes were sensitive to the light; they don't feel right; it was the worst day; a very bad nausea; splitting headache; backache; muscle ache; didn't have any appetite; she began with symptoms; This spontaneous case was reported by a consumer and describes the occurrence of SYMPTOM RECURRENCE (she began with symptoms), FEELING ABNORMAL (it was the worst day), NAUSEA (a very bad nausea), HEADACHE (splitting headache) and BACK PAIN (backache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Polymyalgia rheumatica and Sjogren's. Concomitant products included HYDROXYCHLOROQUINE, VALSARTAN, HYDROCHLOROTHIAZIDE and FAMOTIDINE for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced SYMPTOM RECURRENCE (she began with symptoms). On 20-Feb-2021, the patient experienced FEELING ABNORMAL (it was the worst day), NAUSEA (a very bad nausea), HEADACHE (splitting headache), BACK PAIN (backache), MYALGIA (muscle ache) and DECREASED APPETITE (didn't have any appetite). On 23-Feb-2021, the patient experienced NAUSEA (nausea again), PHOTOPHOBIA (her eyes were sensitive to the light) and MALAISE (they don't feel right). At the time of the report, SYMPTOM RECURRENCE (she began with symptoms), NAUSEA (a very bad nausea), HEADACHE (splitting headache), BACK PAIN (backache), MYALGIA (muscle ache), DECREASED APPETITE (didn't have any appetite), NAUSEA (nausea again), PHOTOPHOBIA (her eyes were sensitive to the light) and MALAISE (they don't feel right) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included Excedrin: Aspirin/Paracetamol/Caffeine.

Other Meds: HYDROXYCHLOROQUINE; VALSARTAN; HYDROCHLOROTHIAZIDE; FAMOTIDINE

Current Illness: Polymyalgia rheumatica; Sjogren's

ID: 1581640
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shivering; is real hot; stuffy nose; nausea; arm has lump on it; can't even lift arm; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (shivering), HOT FLUSH (is real hot), NASAL CONGESTION (stuffy nose), NAUSEA (nausea) and SKIN MASS (arm has lump on it) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (shivering), HOT FLUSH (is real hot), NASAL CONGESTION (stuffy nose), NAUSEA (nausea), SKIN MASS (arm has lump on it) and MUSCULAR WEAKNESS (can't even lift arm). At the time of the report, CHILLS (shivering), HOT FLUSH (is real hot), NASAL CONGESTION (stuffy nose), NAUSEA (nausea), SKIN MASS (arm has lump on it) and MUSCULAR WEAKNESS (can't even lift arm) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD21-037683 (E2B Linked Report).; Sender's Comments: MOD21-037683:cross link

Other Meds:

Current Illness:

ID: 1581641
Sex: M
Age: 81
State: MD

Vax Date: 02/13/2021
Onset Date: 02/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Some kind of rash at the injection site with a bump in it; This spontaneous case was reported by a consumer and describes the occurrence of in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M2DA) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient was treated with PARAFFIN SOFT (VASELINE [PARAFFIN SOFT]) at an unspecified dose and frequency. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1581642
Sex: F
Age: 87
State: MD

Vax Date: 01/27/2021
Onset Date: 02/12/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for COVID-19 virus; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (Tested positive for COVID-19 virus) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19 virus). At the time of the report, COVID-19 (Tested positive for COVID-19 virus) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, COVID-19: unknown (Positive) unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medication was reported. Patient gave consent to safety for Follow-up.

Other Meds:

Current Illness:

ID: 1581643
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bad rash reaction to the moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (bad rash reaction to the moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (bad rash reaction to the moderna vaccine). At the time of the report, VACCINATION SITE RASH (bad rash reaction to the moderna vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant information provided. No treatment information provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm